Lakefront Biotherapeutics NV (GLPGF)
PNK · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Peers in Healthcare
Lakefront Biotherapeutics NV has no peer companies in this window.
Recent press releases
March 2026
GALAPAGOS NV — 6-K Filing
# 🔥 What This Document Is This is a **6-K report** from Galapagos NV, a Belgian biotech company listed on Euronext and NASDAQ (ticker: GLPG). It’s a current report used to announce major events to investors. This specific filing announces a new, binding collaboration deal with pharmaceutical giant
GALAPAGOS NV — 6-K Filing
# 🧾 What This Document Is This is a **6-K filing** from Galapagos NV, a Belgian biotech company. It's a "current report" filed with the SEC to inform investors of major events. This specific filing announces that Galapagos has published its **2025 Annual Report** and is calling two shareholder meet
SEC filings
All filings →Insider trades
All insider trades →Lakefront Biotherapeutics NV has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Lakefront Biotherapeutics NV
All people →No officers or directors have been indexed for Lakefront Biotherapeutics NV.